Introduction
There is currently considerable effort directed towards generating human hepatocytes from stem cells since these would have both 30 basic science (e.g. drug metabolism and toxicity screening) and clinical (e.g. incorporation into bio-artificial liver devices) applications). 1 However, embryonic stem cells (ESCs) and induced pluripotent stem cells have so far failed in their ability to generate cells with comparable function to human hepatocytes in 35 vitro 2-4 , even after forced over-expression of liver transcription factors. 5 One alternative to using stem cells as a source for hepatocytes, is to use progenitor cells. In the liver, a bi-potential population of progenitor cells located within the ductal regions of the lobule is 40 known to exist although harnessing this resource to generate hepatocytes in vitro has yet to be realised because there is little understanding of how to control their differentiation in vitro. 6 The pancreas -which is developmentally closely related to the liver -also contains a ductal progenitor cell. 7 The rat pancreatic 45 progenitor "B-13" cell line appears to be related to this pancreatic ductal progenitor cell. Critically however, B-13 cells appear to be the only cells capable of generating functional hepatocytes (referred to as B-13/H cells) in vitro. [8] [9] [10] [11] B-13 differentiation into hepatocytes is achieved in a highly cost-effective manner, 50 requiring the addition of a simple glucocorticoid hormone treatment.
1,8-11 B-13/H cells are formed on a simple plastic substratum and, in contrast to normal primary hepatocytes, they remain differentiated for at least several weeks. This contrasts markedly with normal primary rat hepatocytes cultured under the same conditions, which lose most hepatic functions within 2 -3 days of isolation. 1 Over the last few years, we have attempted to place the B-13 60 glucocorticoid response into a physiological context, since a human equivalent would have significant scientific and clinical value. We have shown that treating rats with a synthetic glucocorticoid results in the appearance of acinar cells which stain positive for the expression of hepatocyte markers. 12 In mice with high circulating levels of endogenous glucocorticoid (that gives rise to Cushing's disease-like symptoms by adulthood), a large proportion of the acinar pancreas expressed genes normally restricted to hepatocytes. 13 In a third of these mice, malabsorption developed because of a loss in pancreatic exocrine 5 function. 1, 13 We hypothesized that the uniquely effective differentiation of B-13 cells to B-13/H cells is associated with genetic alterations in the cells that have resulted in a stable progenitor phenotype for at least 17 years (the cells were first derived in the mid 1990s 14 ) and 10 an ability to overcome the three hurdles required to generate hepatocytes in vitro. The data in this paper show that B-13/H cells express similar levels of cytochrome P450 to normal hepatocytes, and that the cytochrome P450 proteins have incorporated protoporphyrin IX and functionality. The B-13 cells 15 which generate these cells had a range of cytogenetic alterations but these alterations did not result in cells that could proliferate in the absence of anchorage in vitro. The data also indicate that B-13 cells retain an apparent bias in their ability to engraft into tissues, engrafting to any significant extent only into the pancreas 20 (the probable tissue of origin 15 ) and the liver. demonstrating an early induction of Sgk1 mRNA expression prior to an induction in Cebp-α and Cebp-β, which increased prior to and simultaneously respectively with the increase in the expression of hepatocyte marker Cyp2e1, Cps1 and albumin mRNAs ( Figure 1A ). The increased expression of Cyp2e1, Cps1 35 and Cepb-β (and other markers, not shown) was observed in the majority of cells by day 14 of treatment with DEX ( Figure 1B ) and to detectable levels of carbon monoxide reduced haemoprotein ( Figure 1C ) that are similar to those found in freshly isolated rat hepatocytes (Table 1) . Functional drug 40 metabolising activity in B-13/H cells was confirmed through the addition of a range of drugs to the culture media and detection of metabolites ( Figure 1D ).
B-13 cells are male cells with chromosomal abnormalities that
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constitutively express pluripotency inducing transcription factors but do not grow in soft agar B-13 cells were cloned from the AR42J cell line in the mid 1990s 14 and have been extensively expanded in culture for at least 17 years. Since this time, the cell line has retained both its 50 proliferative capacity and differentiation response to glucocorticoid, suggestive of genetic alterations that confer a stable phenotype. To confirm if any genetic changes have occurred, the B-13 karyotype was therefore compared to cultured rat liver myofibroblasts (as a normal control) and the human 55 hepatoma HepG2 cancer cell line (as with B-13 cells, both were similarly proliferative under the culture conditions outlined in the methods section). Analysis of each cell karyotype is summarized in Table 2 . These data show that liver myofibroblasts had 42 chromosomes/cell (the normal rat diploid complement of 60 chromosomes) whereas B-13 cells had 84 chromosomes and were near-tetraploid. In contrast, cancer HepG2 cells had an abnormal and variable number of chromosomes compared to a normal human cell. Figure 2A shows a typical karyotype from B-13 cells and illustrates that there were a number of structural 65 abnormalities evident, resulting in the identity of several chromosomes being ambiguous (Table 3) .
Since four transcription factors -c-Myc, Klf-4, Oct-4 and Sox-2 -have been shown to induce pluripotency in cells, 7,16,17 the effect of DEX on their expression was examined. Figure 2B   70 shows that all 4 transcription factors were detectable in B-13 cells and that expression of Klf4, Oct4 and Sox2 were suppressed in B-13/H cells, suggesting a potential role of these factors in B-13 cell phenotype and/or regulation in the differentiation to B-13/H cells. To test this hypothesis, B-13 cells were stably transfected with a 18,19 RT-PCR was used to screen for murine c-Myc induction (note, amino acid-coding mouse and rat Klf4, 85 Oct4 and Sox2 transcripts are highly homologous and primers could not distinguish between them). Figure 2C demonstrates induction of c-Myc transgene expression after DOX treatment (after DNase I treatment of RNA to avoid amplification of genomic c-Myc DNA) in a line successfully generated through 90 this strategy. Figure 2D and E demonstrate that B-13 piggy cells retained their response to DEX treatment and differentiated into B-13/H cells as determined morphologically and through induction of liver-specific gene expression. Treatment with DOX to induce expression of the pluripotency inducing transcription 95 factors resulted in a change of B-13 piggy to a more fibroblastic phenotype. DOX and DEX treatment resulted in significant cell death ( Figure 2D ) with the surviving cells remaining resistant to differentiation into B-13/H cells ( Figure 2E ). Note, that B-13 differentiation into B-13/H cells was also accompanied with ~ 10-100 20% cell death (data not shown).
Normal cell proliferation requires anchorage to a sub-stratum. In contrast, tumourigenic cells proliferate without the requirement for anchorage to a substratum. Figure 2F demonstrates that B-13 cells failed to proliferate in soft agar similarly to liver 105 myofibroblasts, which both proliferated in serum-containing media in vitro. In contrast, the human hepatoma HepG2 cell line -used as a positive control -continued to proliferate in soft agar. Figure 3C ) and protein ( Figure 3D ). B-13/H r cells retained a degree of pancreatic amylase expression ( Figure 3C and 3D ) with the majority of B-13/H r cells expressing liver markers albumin and Cyp2e1 10 compared to undetectable levels of expression of these genes in B-13 r cells ( Figure 3C and 3D ). DsRed fluorescence is therefore likely also to be expressed in B-13 r cells which differentiate into B-13/H r cells in vivo. the liver and pancreas ( Figure 4A ), but were not observed in any other tissues examined (lung, heart, brain, bone marrow, thymus, spleen, kidney and adipose tissue -data not shown). Since amylase expression is retained in B-13/H r cells expressing hepatocyte markers in vitro (see Figure 3C and 3D), expression 25 of amylase was employed as a marker to screen tissues from NOD/SCID mice injected with B-13 r cells. Using RT-PCR primers specific for the rat amylase transcript (rAmylase), Figure  4B shows that B-13 r cells engrafted into both the livers and pancreata of both control and paracetamol pre-treated mice, but 30 not in other tissues. Interestingly, primers specific for the rat cyp2e1 transcript (rCyp2e1) show this transcript was detectable in the livers from several mice injected with B-13 r cells, suggesting that the cells differentiate into B-13/H r cells in the liver, but not in the pancreas (or any other tissue). The more 35 quantitative determination by Western blotting of tissue extracts for amylase expression essentially confirms these data and indicates significant engraftment of B-13 r cells into the liver but not other tissues ( Figure 4C ). Figure 4D further confirms these observations, showing typical immunohistochemical staining in 40 liver for amylase expression and comparative results in lung and heart. There was also no evidence of B-13 r engraftment using amylase as a probe in bone marrow, brain, thymus, spleen, kidney and adipose tissue (data not shown). Despite the fact that paracetamol injures the centrilobular region of the liver lobule -45 zone 3 of the acinus 17 , B-13 cells consistently engrafted into the periportal region of the lobule in both control and paracetamol pre-treated mice.
B-
The cytogenetic data in Figure 2A suggests that the B-13 cell line was derived from a male rat since all the chromosomal 50 spreads examined contained two Y chromosomes (since the cells were tetraploid). Figure 5A and 5B confirm that B-13 cells are male cells since a sequence of DNA present only on the rat Y chromosome was amplified from DNA isolated from either B-13 cells or male rats (but not from DNA isolated from female rats) 55 and Y chromosome FISH bound only to cultured B-13 or male rat cells respectively. Figure 5C genes. Previous work has shown that ectopic expression of Cebp-β alone is sufficient to induce a B-13/H-like phenotype in B-13 cells. 8 The data presented in this work however, reports a prior induction of Cebp-α, which may suggest that this transcription factor may control earlier events in hepatic 85 differentiation.
Data in this paper also demonstrate for the first time that B-13 cells have a number of chromosomal changes (but retain a 4n complement of chromosomes), a feature typical of many dividing cells that have been propagated for some time in vitro but have 90 not undergone transformation, such as ESC lines. 20 B-13 cells also expressed the four pluripotency inducing transcription factors, c-Myc, Klf4, Oct4 and Sox2. Previous data has shown that B-13 cells readily differentiate into hepatocytes but are resistant to de-differentiation (i.e. they maintain their hepatocyte 95 progenitor phenotype) and do not differentiate into any other cell type. 1, 10 The data in this paper indicate that Klf4, Oct4 and Sox2 expression falls as B-13 cells differentiate into B-13/H cells and suggest that a suppression of at least Klf4, Oct4 and Sox2 is required for differentiation, since their forced over-expression 100 completely blocked differentiation into B-13/H cells in response to DEX. Interestingly, the continued propagation of B-13 piggy with transgene selection did not maintain the fibroblastic phenotype initially observed and there was a return to the B-13 phenotype and normal B-13/H formation in response to DEX 105 (without loss of DOX-dependent c-Myc induction, data not shown). These observations suggest that the potential plasticity induced by over-expression of c-Myc, Klf4, Oct4 and Sox2 is counteracted by an unidentified factor(s) in B-13 cells, which may be essential for its progenitor status and restricted 110 differentiation potential.
The identification and controlled expression of this factor(s) will likely be important in controlling progenitor cells and hepatocyte production therefrom.
B-13 cells also did not grow in soft agar, indicating that they retain a requirement for anchorage-dependent growth and 115 responsiveness to factors which prevent un-controlled cell growth. On this basis, the cells could be defined as untransformed and potentially non-cancerous. This is supported by the fact that B-13 cells did not give rise to tumours (or teratomas) when injected into NOD/SCID mice, although longer periods of time (> 1year) would be required to fully test this hypothesis.
Interestingly, the cells appeared to specifically engraft only in the liver and pancreas. Hepatic engrafted B-13 cells differentiated into hepatocytes and appeared to down regulate amylase expression (which is down-regulated but not lost when B-13 cells are converted to B-13/H cells in vitro) as the cells moved into the 10 parenchyma. In contrast, on the basis of primer pairs selective for rat amylase and rat Cyp2e1 transcripts, B-13 cells did not differentiate into hepatocytes in the pancreas despite clear evidence (using the rat amylase-specific transcript PCR primer pairs) that B-13 cells engrafted into the pancreata of mice (the 15 high levels of degradative enzymes present in acinar pancreas prevented an effective FISH analysis in pancreas tissue).
Of fundamental importance and utility, B-13 cells are readily propagated in simple culture media; are expanded on plastic culture ware and require a single chemical hormone to drive a 20 change in differentiation. 1, 10 Furthermore, the majority ( > 80%) of B-13 cells differentiate into B-13/H cells and express a vast array of liver-specific or liver-enriched genes at quantitatively similar levels to hepatocytes freshly isolated from rats. 1, 10 The remaining cells retain a B-13 phenotype, which likely explains 25 why this cell line remains in existence so long after its isolation (i.e. factors within the culture prevent some cells from differentiating from the progenitor phenotype). Although the B-13 response mirrors a pathophysiological response of the acinar pancreas to elevated -Cushing's disease levels -of 30 glucocorticoid, 13 the unique features of B-13 cell differentiation are likely dependent on some of the chromosomal changes that have occurred in this cell line. Yet these changes may not have transformed the cell into a fully neoplastic phenotype.
Hepatocytes are a valuable resource for screening drugs and 35 chemicals for metabolism and toxicity. 1 The B-13 cell alone could be a valuable tool in in vitro toxicity and genotoxicity testing, since it retains the ability to express drug and chemical metabolic activity in the B-13/H phenotype. Accordingly, the B-13 cell has considerable "3Rs" potential since safety testing can 40 not only be performed in vitro, but be performed without the requirement for animal donors.
Materials and methods
45
Plasmid DNA constructs The piggybac vectors PB-CA-rTA Adv and PB-TET-MKOS 18, 19 were supplied by Dr Andras Nagy (Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada). pCyL4321 was obtained from Wellcome Trust Sanger Institute (Cambridge, 50 UK).
The pDsRed2-C1 construct encoding a red fluorescent protein was purchased from Clontech.
Cell isolation and culture B-13 cells and the human hepatoma HepG2 cell line were 55 routinely cultured in Dulbecco's minimum essential medium (DMEM) supplemented with 10% (v/v) foetal calf serum (FCS), 80u/ml penicillin and 80µg/ml streptomycin.
Rat liver myofibroblasts were generated from the culture activation of quiescent hepatic stellate cells essentially as previously 60 described. 22 Myofibroblasts were cultured in DMEM containing 4.5g/l of glucose and supplemented with 16% (v/v) FCS, 80u/ml penicillin and 80u/ml streptomycin. Rat hepatocytes were prepared by collagenase perfusion essentially as previously described.
9 All cells were incubated at 37 o C in an humidified Oct4 and Sox2 under regulation of the tetO2 tetracycline/doxycycline inducible promoter. Piggybac transgene expression was induced through treatment with doxycyclin (DOX) at 100 µg/ml. B-13 cells stably expressing the DsRed fluorescent protein (B-13 r ) were generated by transfection with 90 the pDsRed2-C1 construct followed by selection using G418 (200 -500 µg/ml). For cultures in soft agar, cells were trypsinised from the standard cultures and re-suspended in media containing 0.35% (w/v) agarose and at a concentration of 2.5 x10 3 cells/ml for 95 potential to grow in soft agar essentially as previously outlined.
23
The cell/agarose mixture (1ml per well) was overlaid onto a solidified base layer containing cell media and 0.5% (w/v) agarose. Once solidified, each well was supplemented with 500µl of cell media to prevent drying out. The cells were then cultured 100 for 2 weeks, with regular additions of fresh cell media, before staining each well with 500µl of 0.005% (w/v) crystal violet for 1 hour. Colonies were imaged using an Optika microscope and images recorded using a BUC2-500c camera (Bestscope International Ltd).
105
RT-PCR and PCR
Total RNA was purified using Trizol (Invitrogen, Paisley, UK) and RT-PCR performed and analysed essentially as previously outlined. 10 Foetal RNA was prepared from foetuses isolated and 110 pooled from pregnant female rats at day 12 after conception (time from vaginal plug formation). Primer sequences for the amplification of rat cytochrome P450 2E1 (Cyp2e1), rat amylase, rat Cps1, rat albumin and glyceraldehyde-3-phosphate dehydrogenase (Gapdh) have been published previously. 10 Other 115 primer sequences are given in Table 4 . Quantitative RT-PCR employed the use of an Applied Biosystems7500 Real-Time PCR machine, using SYBR® Green Jumpstart™ mastermix (SigmaAldrich, UK), with 2µM forward and reverse primer. Primer sequences are given in Table 4 Genomic DNA was isolated from B-13 cells and rats as 5 previously described 13 and subjected to PCR analysis for the presence of a non-coding X chromosome-specific sequence within the ZFX zinc finger protein; a non-coding Y chromosome specific sequence (testis-specific protein TSPY gene) and a control non-coding, non-sex chromosome sequence (promoter 10 region of the rat Cyp2e1 gene). For details of the primer sequences employed and the regions amplified, see Table 4 .
Western blotting
Western blotting was performed essentially as previously 15 outlined with antibodies described previously.
10,11 Detection was achieved using an ECL kit (Amersham, UK).
Immunohistochemistry
Cultured cells were prepared by permeabilising in ice-cooled 20 methanol for 10 minutes before washing in 1xPBS and fixing in 2% w/v formaldehyde and 0.2% gluteraldehyde in 1xPBS pH 7.4. Tissues were fixed in formalin and processed for immunohistochemistry as previously outlined with antigen retrieval using 0.01M citrate buffer. 24 Non-specific binding of 
Drug Metabolism assays
Total spectrophotometric cytochrome P450 was determined as outlined. 25 Drug metabolising activity of cells in culture was 35 determined through the addition of phenacetin, diclofenac (both from Sigma-Aldrich, St. Louis, MO), buproprion (Toronto Research Chemicals, North York, Canada) and midazolam (Roche, Mannheim, Germany) as a cocktail with final concentrations in the medium of 26µM, 9µM, 100µM and 3µM 40 respectively. Samples of media were taken at 1 and 3 hours after addition of substrates and frozen at -80°C until analysis. The concentrations of metabolites were analysed at Pharmacelsus GmbH, Saarbrücken, Germany, as previously described. 26 The formation rate of metabolites was calculated from the slope of the 
Fluorescence in Situ Hybridisation (FISH)
FISH was carried out essentially described, 27 with some modifications. In brief, paraffin-embedded tissue sections were mounted onto coated slides and baked overnight at 55°C. Slides 90 were de-paraffinised in 3 changes of xylene at room temperature for 10 minutes before dehydrating in two changes of 100% ethanol for 5 minutes and air drying. Sections were then incubated in 0.2M HCl for 20 minutes and subsequently washed twice in 2X saline-sodium citrate (SSC) buffer (1X SSC consists 95 of 150mM NaCl, 340mM Na 3 Citrate pH 7.4) for 5 minutes, followed by incubation in 1M NaSCN at 80°C for 10 minutes before two further 5 minute washes in 2X SSC. Tissue digestion was performed by incubating sections at 37°C overnight with 0.4% (w/v) pepsin in 0.001M HCl. Sections were then washed 100 twice in 2X SSC and air dried before re-fixation in 10% formalin in 1xPBS for 15 minutes. Slides were washed twice with 2X SSC and air dried before addition of 10µl of RatIDetectTM Chr Y FISH paint probe (Cambio) and sections sealed with coverslips. The slides were then heated to 90°C for 5 minutes to denature 105 double stranded DNA and the probe hybridised overnight at 37°C in an humidified environment. After hybridization, coverslips were removed by soaking in 2X SSC and sections subjected to post-hybridisation washes twice in 2X SSC/0.1% (v/v) Tween-20 at 45°C followed by two washes in 0.5 X SSC/0.1% (v/v) Tween-110 20 at 45°C. Slides were briefly rinsed in H 2 O and air dried in the dark prior to staining with 4'-6',-diamidino-2-pheylindole and anti-fade compound (Vectashield), coverslipping, sealing and microscopic examination using a Zeiss AxioImager microscope using excitation and emission wavelength of 611 and 631nm experiments. B-13 cells did not contain detectable levels of either P420 or CYP450 (see Table 1 ). D, Metabolism of phenacetin, diclofenac, midazolam and bupropion to paracetamol, and hydroxylated products respectively. Data are the mean and standard deviation of 3 separate experiments. r cell engraftment in the liver and evidence for differentiation to B-13/H r in vivo. A, PCR amplification from DNA isolated from B-13 cells, male or female rats. Primer sequences which specifically anneal to sequences within the indicated chromosome are given in Table 3 . PCR control, amplification in the absence of DNA template. B, FISH analysis for the Y chromosome in B-13 cells and in liver myofibroblasts isolated from male or female rats. "-probe", procedure undertaken in the absence of Y probe as 45 a control. White arrow indicates high magnification view on right of panel; C, Y chromosome FISH in liver sections prepared from the indicated sex and species, demonstrating that FISH is specific for male rat cells and that the probe does not hybridise to female rat cells or male NOD/SCID cells. D, Serial sections immunostained for amylase (left) and Y chromosome FISH (right) in a liver section from a paracetamol-treated NOD/SCID mouse injected with B-13 cells; E, DAPI and albumin stained sections of liver from PBS control of B-13 r injected NOD/SCID mice imaged for the indicated marker.
